These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15248376)

  • 1. Absence of an association of the IBD2 locus gene keratin 8 and inflammatory bowel disease in a large genetic association study.
    de Jong DJ; Drenth JP
    Dig Liver Dis; 2004 Jun; 36(6):380-3. PubMed ID: 15248376
    [No Abstract]   [Full Text] [Related]  

  • 2. Keratin mutations and intestinal pathology.
    Owens DW; Lane EB
    J Pathol; 2004 Nov; 204(4):377-85. PubMed ID: 15495267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human keratin 8 mutations that disturb filament assembly observed in inflammatory bowel disease patients.
    Owens DW; Wilson NJ; Hill AJ; Rugg EL; Porter RM; Hutcheson AM; Quinlan RA; van Heel D; Parkes M; Jewell DP; Campbell SS; Ghosh S; Satsangi J; Lane EB
    J Cell Sci; 2004 Apr; 117(Pt 10):1989-99. PubMed ID: 15090596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of genotype-phenotype relationships and stratification by the CARD15 variant genotype for inflammatory bowel disease susceptibility loci using multiple short tandem repeat genetic markers.
    Crawford NP; Colliver DW; Funke AA; Young MN; Kelley S; Cobbs GA; Petras RE; Galandiuk S
    Hum Mutat; 2005 Feb; 25(2):156-66. PubMed ID: 15643611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keratin 8 Y54H and G62C mutations are not associated with inflammatory bowel disease.
    Büning C; Halangk J; Dignass A; Ockenga J; Deindl P; Nickel R; Genschel J; Landt O; Lochs H; Schmidt H; Witt H
    Dig Liver Dis; 2004 Jun; 36(6):388-91. PubMed ID: 15248378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease. II. Gene mapping.
    Taylor KD; Yang H; Rotter JI
    Mol Genet Metab; 2001; 74(1-2):22-44. PubMed ID: 11592801
    [No Abstract]   [Full Text] [Related]  

  • 7. [Genetics of inflammatory bowel disease].
    Zouiten ML; Khalfaoui T; Boubaker J; Chaabouni H; Filali A; Mechmeche R
    Tunis Med; 2004 Jul; 82(7):635-41. PubMed ID: 15552020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory bowel disease--environmental modification and genetic determinants.
    Kugathasan S; Amre D
    Pediatr Clin North Am; 2006 Aug; 53(4):727-49. PubMed ID: 16873002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD2BP1 and CARD15 mutations are not associated with pyoderma gangrenosum in patients with inflammatory bowel disease.
    Newman B; Cescon D; Domenchini A; Siminovitch KA
    J Invest Dermatol; 2004 Apr; 122(4):1054-6. PubMed ID: 15102098
    [No Abstract]   [Full Text] [Related]  

  • 10. Understanding association and causality in the genetic studies of inflammatory bowel disease.
    Trinh TT; Rioux JD
    Gastroenterology; 2005 Dec; 129(6):2106-10. PubMed ID: 16344078
    [No Abstract]   [Full Text] [Related]  

  • 11. Inflammatory bowel disease. I. Genetic epidemiology.
    Yang H; Taylor KD; Rotter JI
    Mol Genet Metab; 2001; 74(1-2):1-21. PubMed ID: 11592800
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress towards identifying inflammatory bowel disease susceptibility genes.
    Rioux JD
    Novartis Found Symp; 2004; 263():3-11; discussion 11-6, 211-8. PubMed ID: 15669631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying susceptibility to inflammatory bowel diseases: a candidate gene approach, genome-wide association studies, or both?
    Pavli P; Summers KM
    J Gastroenterol Hepatol; 2008 Jan; 23(1):6-7. PubMed ID: 18171338
    [No Abstract]   [Full Text] [Related]  

  • 14. Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease.
    Oostenbrug LE; Dijkstra G; Nolte IM; van Dullemen HM; Oosterom E; Faber KN; de Jong DJ; van der Linde K; te Meerman GJ; van der Steege G; Kleibeuker JH; Jansen PL
    Scand J Gastroenterol; 2006 Oct; 41(10):1174-82. PubMed ID: 16990202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of multiple candidate genes for IBD susceptibility using high-density transcript mapping in the IBD2 locus on chromosome 12q.
    Hamlin PJ; Komolmit P; Bransfield K; Jones PF; Smith NR; Aldersley MA; Howdle PD; Markham AF; Robinson PA
    Gastroenterology; 1999 Oct; 117(4):1029-31. PubMed ID: 10576977
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic profiling in inflammatory bowel disease: from association to bedside.
    Van Limbergen J; Philpott D; Griffiths AM
    Gastroenterology; 2011 Nov; 141(5):1566-71.e1. PubMed ID: 21939623
    [No Abstract]   [Full Text] [Related]  

  • 18. Keratins as susceptibility genes for end-stage liver disease.
    Ku NO; Lim JK; Krams SM; Esquivel CO; Keeffe EB; Wright TL; Parry DA; Omary MB
    Gastroenterology; 2005 Sep; 129(3):885-93. PubMed ID: 16143128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetics of inflammatory bowel disease.
    Van Limbergen J; Russell RK; Nimmo ER; Satsangi J
    Am J Gastroenterol; 2007 Dec; 102(12):2820-31. PubMed ID: 17894847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-gene interactions in inflammatory bowel disease: biological and clinical implications.
    Achkar JP; Fiocchi C
    Am J Gastroenterol; 2009 Jul; 104(7):1734-6. PubMed ID: 19436278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.